The Northern Powerhouse plays a vital role in Pharma Manufacturing
With more than 1,000 life science companies operating across the region and with the North East producing 33% of UK GDP in pharmaceutical manufacturing and 31% of contract research organisations based in the North West, the North of England’s life science sector is worth more than £13.6bn.
Bionow’s Pharma Manufacturing conference will bring together industry, academic and regulatory experts to collaborate and share their experiences and expertise through talks, panel discussions, exhibitions and networking to identify challenges and opportunities in the industry.
The life sciences industry requires a joined-up approach
The sector continues to face challenges, such as attracting the right talent, managing increasing costs, adopting ethical practices, investing in new technologies and supply chain disruption. There are also many opportunities to grow, including access to funding at local and national levels, working collaboratively across industry, academia and the public sector, developing more sustainable manufacturing practices and utilising developments in new therapies to streamline routes to market.
Get involved at Pharma Manufacturing 2024 as we highlight and celebrate the North’s world-class manufacturing sector.
Buy tickets
This event is part of
